Integral Ad Science (NASDAQ:IAS) PT Lowered to $12.00

Integral Ad Science (NASDAQ:IASFree Report) had its price target cut by Barclays from $16.00 to $12.00 in a research note published on Monday, Benzinga reports. They currently have an equal weight rating on the stock.

Several other brokerages have also recently weighed in on IAS. Truist Financial lowered their price target on shares of Integral Ad Science from $26.00 to $17.00 and set a buy rating for the company in a research report on Wednesday, February 28th. Piper Sandler lowered their price target on shares of Integral Ad Science from $20.00 to $18.00 and set an overweight rating for the company in a research report on Wednesday, February 28th. BMO Capital Markets lowered their price target on shares of Integral Ad Science from $18.00 to $16.00 and set an outperform rating for the company in a research report on Wednesday, February 28th. Bank of America initiated coverage on shares of Integral Ad Science in a research report on Thursday, January 11th. They issued a buy rating and a $19.00 price target for the company. Finally, Raymond James cut shares of Integral Ad Science from a strong-buy rating to an outperform rating and lowered their price target for the stock from $20.00 to $16.00 in a research report on Wednesday, February 28th. Three analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. According to MarketBeat, Integral Ad Science presently has an average rating of Moderate Buy and a consensus price target of $17.58.

View Our Latest Stock Report on Integral Ad Science

Integral Ad Science Price Performance

Integral Ad Science stock opened at $9.10 on Monday. The stock has a market cap of $1.45 billion, a price-to-earnings ratio of 227.56, a price-to-earnings-growth ratio of 1.65 and a beta of 1.60. The company has a debt-to-equity ratio of 0.17, a current ratio of 3.21 and a quick ratio of 3.21. Integral Ad Science has a 1 year low of $9.08 and a 1 year high of $20.88. The firm has a 50-day moving average of $11.42 and a two-hundred day moving average of $13.04.

Integral Ad Science (NASDAQ:IASGet Free Report) last released its quarterly earnings data on Tuesday, February 27th. The company reported $0.06 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.03 by $0.03. The company had revenue of $134.30 million during the quarter, compared to analysts’ expectations of $131.27 million. Integral Ad Science had a net margin of 1.53% and a return on equity of 0.83%. The firm’s quarterly revenue was up 14.4% on a year-over-year basis. During the same period in the previous year, the company earned $0.07 EPS. On average, research analysts forecast that Integral Ad Science will post 0.16 earnings per share for the current year.

Insider Buying and Selling at Integral Ad Science

In other Integral Ad Science news, CEO Lisa Utzschneider sold 13,113 shares of the firm’s stock in a transaction on Tuesday, February 6th. The shares were sold at an average price of $15.79, for a total value of $207,054.27. Following the completion of the transaction, the chief executive officer now owns 148,657 shares of the company’s stock, valued at $2,347,294.03. The transaction was disclosed in a filing with the SEC, which is available at this link. In other Integral Ad Science news, CAO Alexis Gil II sold 3,177 shares of the firm’s stock in a transaction on Monday, March 4th. The shares were sold at an average price of $10.24, for a total value of $32,532.48. Following the completion of the transaction, the chief accounting officer now owns 120,195 shares of the company’s stock, valued at $1,230,796.80. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, CEO Lisa Utzschneider sold 13,113 shares of the firm’s stock in a transaction on Tuesday, February 6th. The stock was sold at an average price of $15.79, for a total transaction of $207,054.27. Following the completion of the transaction, the chief executive officer now directly owns 148,657 shares of the company’s stock, valued at approximately $2,347,294.03. The disclosure for this sale can be found here. Insiders sold a total of 80,195 shares of company stock worth $876,562 over the last three months. Corporate insiders own 2.00% of the company’s stock.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. JPMorgan Chase & Co. raised its holdings in shares of Integral Ad Science by 286.0% during the first quarter. JPMorgan Chase & Co. now owns 119,294 shares of the company’s stock worth $1,646,000 after purchasing an additional 88,390 shares during the last quarter. Bank of New York Mellon Corp raised its holdings in shares of Integral Ad Science by 74.3% during the first quarter. Bank of New York Mellon Corp now owns 87,728 shares of the company’s stock worth $1,210,000 after purchasing an additional 37,393 shares during the last quarter. Bank of Montreal Can raised its holdings in shares of Integral Ad Science by 3.5% during the first quarter. Bank of Montreal Can now owns 149,859 shares of the company’s stock worth $2,155,000 after purchasing an additional 5,018 shares during the last quarter. MetLife Investment Management LLC raised its holdings in shares of Integral Ad Science by 185.3% during the first quarter. MetLife Investment Management LLC now owns 19,760 shares of the company’s stock worth $273,000 after purchasing an additional 12,835 shares during the last quarter. Finally, Rhumbline Advisers raised its holdings in shares of Integral Ad Science by 112.4% during the first quarter. Rhumbline Advisers now owns 33,014 shares of the company’s stock worth $456,000 after purchasing an additional 17,470 shares during the last quarter. Hedge funds and other institutional investors own 95.78% of the company’s stock.

About Integral Ad Science

(Get Free Report)

Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.

Recommended Stories

Analyst Recommendations for Integral Ad Science (NASDAQ:IAS)

Receive News & Ratings for Integral Ad Science Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integral Ad Science and related companies with MarketBeat.com's FREE daily email newsletter.